Endoscopic Devices - Malta | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Malta is anticipated to attain US$3.63m in 2024.
The revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 8.99%, leading to a market volume of US$5.58m by 2029.
In a global context, the majority of revenue will be produced the United States, which is projected to generate US$10.39bn in 2024.
Malta's healthcare system is increasingly adopting advanced endoscopic devices, driven by a growing emphasis on minimally invasive procedures and improved patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Malta has been witnessing considerable growth, fueled by advancements in minimally invasive procedures, increasing prevalence of chronic diseases, and heightened demand for efficient diagnostic tools among healthcare providers and patients.

Customer preferences: Consumers in Malta are increasingly prioritizing personalized healthcare solutions, driving a growing interest in advanced endoscopic devices that offer tailored diagnostic and treatment options. As the population ages and the prevalence of chronic diseases rises, patients are placing greater emphasis on minimally invasive techniques that promise quicker recovery times and less discomfort. Additionally, there is a rising awareness of preventive healthcare, prompting individuals to seek out proactive screening methods, further fueling demand for innovative endoscopic technologies.

Trends in the market: In Malta, the Endoscopic Devices Market is experiencing a significant shift toward innovative, minimally invasive surgical techniques, driven by an aging population and a rise in chronic illnesses. Healthcare providers are increasingly adopting advanced endoscopic technologies that enhance diagnostic precision and patient comfort. There is also a growing emphasis on preventive care, encouraging the use of endoscopic procedures for early detection of diseases. This trend not only improves patient outcomes but also alters the landscape for medical device manufacturers, who must prioritize the development of cutting-edge solutions to meet evolving healthcare demands.

Local special circumstances: In Malta, the Endoscopic Devices Market is uniquely influenced by its small population and limited healthcare resources, prompting a strong focus on cost-effective, high-quality medical technologies. The island's geographical constraints necessitate efficient healthcare delivery, making minimally invasive procedures attractive for both patients and providers. Additionally, Malta's regulatory environment supports rapid innovation while emphasizing patient safety, encouraging collaboration between local medical device manufacturers and international firms. This dynamic fosters a competitive landscape that prioritizes advanced endoscopic solutions tailored to the specific needs of the Maltese population.

Underlying macroeconomic factors: The Endoscopic Devices Market in Malta is shaped by a variety of macroeconomic factors, including the country's economic stability, healthcare investment, and demographic trends. With a focus on cost-effective healthcare solutions, Malta's national economic health plays a crucial role in funding medical technologies, influencing purchasing decisions within healthcare systems. Additionally, global trends towards minimally invasive procedures are mirrored in local practices, encouraging the adoption of advanced endoscopic devices. Fiscal policies promoting healthcare innovation and collaboration further enhance market growth, as regulatory support enables local manufacturers to compete internationally while addressing the specific needs of Malta’s population.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.